Akebia Therapeutics (NQ: AKBA )

Date	Open	High	Low	Close	Volume	Change (%)
Aug 31, 2021	2.830	2.990	2.820	2.940	2,456,306	+0.12(+4.26%)
Aug 30, 2021	2.790	2.900	2.781	2.820	1,991,488	-0.03(-1.05%)
Aug 27, 2021	2.650	2.870	2.620	2.850	3,677,071	+0.24(+9.20%)
Aug 26, 2021	2.680	2.770	2.600	2.610	1,610,532	-0.07(-2.61%)
Aug 25, 2021	2.630	2.740	2.570	2.680	1,617,775	+0.07(+2.68%)
Aug 24, 2021	2.700	2.740	2.570	2.610	1,548,244	-0.05(-1.88%)
Aug 23, 2021	2.560	2.685	2.510	2.660	2,294,971	+0.15(+5.98%)
Aug 20, 2021	2.360	2.520	2.360	2.510	2,307,491	+0.16(+6.81%)
Aug 19, 2021	2.430	2.490	2.350	2.350	3,242,378	-0.08(-3.29%)
Aug 18, 2021	2.560	2.580	2.410	2.430	2,981,025	-0.13(-5.08%)
Aug 17, 2021	2.410	2.560	2.402	2.560	1,926,009	+0.12(+4.92%)
Aug 16, 2021	2.500	2.515	2.430	2.440	2,362,744	-0.08(-3.17%)
Aug 13, 2021	2.630	2.640	2.510	2.520	1,774,467	-0.11(-4.18%)
Aug 12, 2021	2.620	2.660	2.540	2.630	1,800,843	+0.06(+2.33%)
Aug 11, 2021	2.690	2.725	2.530	2.570	3,692,698	-0.07(-2.65%)
Aug 10, 2021	2.770	2.770	2.610	2.640	3,408,642	-0.09(-3.30%)
Aug 09, 2021	2.760	2.820	2.700	2.730	4,483,144	-0.01(-0.36%)
Aug 06, 2021	2.780	2.869	2.720	2.740	3,801,143	-0.13(-4.53%)
Aug 05, 2021	2.410	2.870	2.410	2.870	5,751,061	+0.39(+15.73%)
Aug 04, 2021	2.540	2.660	2.480	2.480	2,634,352	-0.09(-3.50%)
Aug 03, 2021	2.610	2.635	2.490	2.570	2,047,447	-0.03(-1.15%)
Aug 02, 2021	2.500	2.625	2.460	2.600	1,821,535	+0.13(+5.26%)
Jul 30, 2021	2.540	2.580	2.450	2.470	2,028,120	-0.05(-1.98%)
Jul 29, 2021	2.630	2.675	2.520	2.520	2,451,830	-0.12(-4.55%)
Jul 28, 2021	2.540	2.640	2.510	2.640	2,945,616	+0.11(+4.35%)
Jul 27, 2021	2.470	2.580	2.360	2.530	4,998,273	+0.06(+2.43%)
Jul 26, 2021	2.480	2.560	2.430	2.470	5,012,746	-0.01(-0.40%)
Jul 23, 2021	2.600	2.610	2.470	2.480	6,169,760	-0.07(-2.75%)
Jul 22, 2021	2.740	2.740	2.550	2.550	7,249,732	-0.15(-5.56%)
Jul 21, 2021	2.680	2.780	2.570	2.700	12,558,134	+0.03(+1.12%)
Jul 20, 2021	2.900	2.926	2.660	2.670	11,416,093	-0.21(-7.29%)
Jul 19, 2021	3.030	3.040	2.840	2.880	6,775,487	-0.22(-7.10%)
Jul 16, 2021	3.470	3.470	3.100	3.100	7,042,992	-0.22(-6.63%)
Jul 15, 2021	3.500	3.597	3.310	3.320	3,156,952	-0.22(-6.21%)
Jul 14, 2021	3.330	3.627	3.320	3.540	8,697,382	+0.21(+6.31%)
Jul 13, 2021	3.310	3.360	3.260	3.330	2,926,022	-0.01(-0.30%)
Jul 12, 2021	3.410	3.440	3.270	3.340	3,261,849	-0.07(-2.05%)
Jul 09, 2021	3.410	3.430	3.330	3.410	1,126,316	+0.01(+0.29%)
Jul 08, 2021	3.280	3.430	3.240	3.400	1,959,093	+0.02(+0.59%)
Jul 07, 2021	3.500	3.550	3.360	3.380	2,477,445	-0.13(-3.70%)
Jul 06, 2021	3.670	3.709	3.480	3.510	2,432,761	-0.20(-5.39%)
Jul 02, 2021	3.880	3.900	3.680	3.710	1,491,923	-0.17(-4.38%)
Jul 01, 2021	3.870	3.910	3.750	3.880	2,000,509	+0.09(+2.37%)
Jun 30, 2021	3.870	3.895	3.780	3.790	1,515,998	-0.07(-1.81%)
Jun 29, 2021	4.091	4.091	3.860	3.860	2,498,332	-0.22(-5.39%)
Jun 28, 2021	4.250	4.330	4.040	4.080	2,148,467	-0.12(-2.86%)
Jun 25, 2021	4.150	4.250	4.080	4.200	8,486,689	+0.02(+0.48%)
Jun 24, 2021	3.930	4.180	3.920	4.180	4,659,054	+0.22(+5.56%)
Jun 23, 2021	3.600	3.960	3.600	3.960	10,081,349	+0.34(+9.39%)
Jun 22, 2021	3.580	3.645	3.550	3.620	1,604,637	-0.02(-0.55%)
Jun 21, 2021	3.690	3.689	3.550	3.640	2,373,612	-0.04(-1.09%)
Jun 18, 2021	3.650	3.730	3.563	3.680	8,553,120	+0.01(+0.27%)
Jun 17, 2021	3.520	3.696	3.510	3.670	2,960,288	+0.14(+3.97%)
Jun 16, 2021	3.490	3.560	3.395	3.530	2,624,985	+0.01(+0.28%)
Jun 15, 2021	3.660	3.670	3.470	3.520	5,338,385	-0.13(-3.56%)
Jun 14, 2021	3.660	3.730	3.590	3.650	3,391,279	-0.02(-0.54%)
Jun 11, 2021	3.720	3.740	3.630	3.670	1,916,966	-0.02(-0.54%)
Jun 10, 2021	3.650	3.740	3.620	3.690	1,979,880	+0.01(+0.27%)
Jun 09, 2021	3.590	3.750	3.568	3.680	3,908,143	+0.08(+2.22%)
Jun 08, 2021	3.430	3.600	3.400	3.600	4,004,790	+0.16(+4.65%)
Jun 07, 2021	3.360	3.480	3.300	3.440	5,023,308	+0.08(+2.38%)
Jun 04, 2021	3.380	3.420	3.310	3.360	2,139,568	+0.03(+0.90%)
Jun 03, 2021	3.280	3.385	3.270	3.330	2,784,137	-0.04(-1.19%)
Jun 02, 2021	3.380	3.440	3.230	3.370	5,341,869	-0.04(-1.17%)

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.